3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
26
Carcinoma, Non-Small-Cell Lung
6
Melanoma
4
Carcinoma, Renal Cell
4
Uterine Cervical Neoplasms
3
Stomach Neoplasms
3
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Neoplasms
2
Mesothelioma
2
Head and Neck Neoplasms
2
Cholangiocarcinoma
2
Bile Duct Neoplasms
2
Vulvar Neoplasms
1
Uveal Melanoma
1
Urothelial Cancer
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Parotid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Interventions
TIC10 compound
4
trametinib
3
dabrafenib
3
vorasidenib
1
ulixertinib
1
trastuzumab biosimilar HLX02
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
entrectinib
1
defactinib
1
copanlisib
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Vincristine
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Nuclear Medicine Department, Hospital
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Glioma
×
pembrolizumab
×
Clear all
No trials found.